New implant fights sarcoma recurrence in early trial
NCT ID NCT04619056
First seen Feb 22, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This early-stage trial tested a new membrane placed during surgery to deliver chemotherapy directly to the tumor site in 21 adults with recurrent or advanced retroperitoneal sarcoma. The goal was to find a safe dose and see if it could delay cancer return. Results are still being analyzed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundación Jiménez Díaz
Madrid, Madrid, 28040, Spain
-
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, 28007, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, Barcelona, 08035, Spain
-
Hospital Universitario y Politécnico La Fe
Valencia, Valencia, 46026, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, 08041, Spain
Conditions
Explore the condition pages connected to this study.